Dahui Zhou
Pfizer (United States)(US)First Affiliated Hospital of Bengbu Medical College(CN)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Receptor Mechanisms and Signaling, Neurotransmitter Receptor Influence on Behavior, Coordination Chemistry and Organometallics
Most-Cited Works
- → Location Matters: Site of Conjugation Modulates Stability and Pharmacokinetics of Antibody Drug Conjugates(2013)488 cited
- → Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design(2016)201 cited
- → Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)(2017)199 cited
- → Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loading(2015)166 cited
- → Enantiomeric separation and determination of absolute stereochemistry of asymmetric molecules in drug discovery—Building chiral technology toolboxes(2007)102 cited
- → RN927C, a Site-Specific Trop-2 Antibody–Drug Conjugate (ADC) with Enhanced Stability, Is Highly Efficacious in Preclinical Solid Tumor Models(2016)99 cited